Patient Stories

HEAR FROM PEOPLE
WHO ARE TAKING BRIUMVI

Discover how BRIUMVI is impacting real people with RMS. Hear from people who have included it in their RMS treatment journey.

HEAR FROM PEOPLE WHO ARE TAKING BRIUMVI

Discover how BRIUMVI is impacting real people with RMS. Hear from people who have included it in their RMS treatment journey.

HEAR FROM PEOPLE WHO ARE TAKING BRIUMVI

 

Discover how BRIUMVI is impacting real people with RMS. Hear from people who have included it in their RMS treatment journey.

These individual stories feature people who have taken BRIUMVI for their RMS – either as a first treatment or after trying other options. Hear why thousands of people, like Mandy, Alex and Meaghan, chose BRIUMVI to take on their RMS.

YouTube player

“When I found out that BRIUMVI was a 1-hour infusion twice a year after the starting dose, I was really drawn to choosing that as my DMT. I have two girls and it’s nice that I can get my infusions while they’re at school and it doesn’t interrupt my time with them.”

 

Mandy, Living with RMS and taking BRIUMVI

Individual results may vary

“Being on an effective medication for my RMS was important to me because I have two young daughters to raise. I feel like BRIUMVI is the right choice for me.”

 

Alex, Living with RMS and taking BRIUMVI

Individual results may vary

YouTube player
YouTube player

“Being on an effective medication for my RMS was important to me because I have two young daughters to raise. I feel like BRIUMVI is the right choice for me.”

 

Alex, Living with RMS and taking BRIUMVI

Individual results may vary

YouTube player

“I love doing anything I can possibly do outside. Aside from the 1-hour infusion time after the first dose, I did my own research, and I was impressed by the efficacy and the safety of BRIUMVI. That is what ultimately led my doctor and I to choose BRIUMVI.”

 

Meaghan, Living with RMS and taking BRIUMVI

Individual results may vary

See All Stories

Diane

Categories: BRIUMVI as 1st treatment

I began experiencing tingling in my right foot. I went to a podiatrist, and she gave me tips as well as treatment, which helped for a while. About a year later, I watched a television talk show where someone shared that her friend had been experiencing tingling in her feet, and she insisted she go see an MS specialist. My tingling continued and I thought about the interview and wondered if maybe I had MS. I went on my daily walk with my dog, and shortly after we began our walk, my tingling got worse. My knees buckled. My gait was off. I started drifting to the right. When I returned home, I went in to my husband, sat down and started crying. I was determined to find out what was going on.

MRIs identified lesions in my brain and spine, and eventually I was diagnosed with RMS. It is suspected that I’d had MS for years before my official diagnosis. I then met with a neurologist for treatment. I had heard of BRIUMVI from a family friend. I knew I wanted an infusion treatment, and I liked the idea of a 1-hour infusion, twice per year after the starting dose. Six months after my first infusion, I had another MRI. There were no active lesions and some of my existing lesions appeared smaller. Woohoo, BRIUMVI was working for me!

MS may have slowed me down a bit, but it hasn’t stopped me from doing anything I used to do. I have had to learn to listen to my body. For me, the most important thing each day is to eat healthy, get exercise, and to have a positive attitude.

 

 

Diane

I’ve been married for 45 years, have 2 children, 6 grandchildren and have always been a dog lover. I’m a Certified Public Accountant and owner of my own consulting practice. I swim and ride my bike every week. I’m a proud, retired, competitive snowboarder. I love to read and put together jigsaw puzzles and create digital art and mixed media pieces.

SHARE YOUR BRIUMVI STORY

Interested in sharing your BRIUMVI experience with others?

BRIUMVI Patient Support

Discover a flexible program designed to support the treatment journey in a way that works best for you.

BRIUMVI® (ublituximab-xiiy) Patient Support logo

FINANCIAL ASSISTANCE

No matter what type of health insurance you have, there may be support to help you afford BRIUMVI. Options may be available for you even if you have no health insurance at all. Learn about the potential options.

People featured on this page are taking BRIUMVI and have been compensated by TG Therapeutics for their time.

INDICATION AND IMPORTANT
SAFETY INFORMATION

Who should not receive BRIUMVI?

Do not receive BRIUMVI if you have an active hepatitis B virus (HBV) infection.

Do not receive BRIUMVI if you have had a life-threatening allergic reaction to BRIUMVI. Tell your healthcare provider if you have had an allergic reaction to BRIUMVI or any of its ingredients in the past.

What is the most important information I should know
about BRIUMVI?

BRIUMVI can cause serious side effects, including:

Infusion reactions: Infusion reactions are one of the most common side effects of BRIUMVI, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and may be monitored after each infusion of BRIUMVI for signs and symptoms of an infusion reaction. Tell your healthcare provider if you get any of these symptoms:

  • fever
  • chills
  • headache
  • flu-like symptoms
  • fast heartbeat
  • hives
  • itchy skin
  • dizziness
  • feeling faint
  • swelling of tongue or throat
  • trouble breathing
  • wheezing
  • nausea
  • abdominal pain
  • throat irritation
  • redness of the face or skin

These infusion reactions can happen over 24 hours after your infusion. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion. If you get an infusion reaction, your healthcare provider may need to stop or slow down the rate of your infusion.

  • Infection:
    • Infections are a common side effect, and upper respiratory tract infections are one of the most common side effects of BRIUMVI. BRIUMVI increases your risk of getting infections caused by bacteria or viruses that may be life-threatening or cause death. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, a cough that does not go away, or painful urination. Your healthcare provider should delay your treatment with BRIUMVI until your infection is gone.
    • Hepatitis B virus (HBV) reactivation: Before starting treatment with BRIUMVI, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with BRIUMVI. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving BRIUMVI.
    • Weakened immune system: BRIUMVI taken before or after other medicines that weaken the immune system could increase your risk of getting infections.
    • Progressive Multifocal Leukoencephalopathy (PML): PML may happen with BRIUMVI. PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These symptoms may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory which may lead to confusion, and personality changes.
  • Low immunoglobulins: BRIUMVI may cause a decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.

Before receiving BRIUMVI, tell your healthcare provider about all of your medical conditions, including if you:

  • have or think you have an infection.
  • take or plan to take medicines that affect your immune system. These medicines may increase your risk of getting an infection.
  • have ever had hepatitis B or are a carrier of the hepatitis B virus.
  • have had a recent vaccination or are scheduled to receive any vaccinations.
    • You should receive any required ‘live’ or ‘live-attenuated’ vaccines at least 4 weeks before you start treatment with BRIUMVI. You should not receive ‘live’ or ‘live-attenuated’ vaccines while you are being treated with BRIUMVI and until your healthcare provider tells you that your immune system is no longer weakened.
    • When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with BRIUMVI. If you would like to receive any non-live vaccines while you are being treated with BRIUMVI, talk to your healthcare provider.
    • If you have a baby and you received BRIUMVI during your pregnancy, it is important to tell your baby’s healthcare provider about receiving BRIUMVI so they can decide when your baby should be vaccinated.
  • are pregnant, think that you might be pregnant, or plan to become pregnant. BRIUMVI may harm your unborn baby. You should use birth control (contraception) during treatment with BRIUMVI and for at least 6 months after your last infusion of BRIUMVI. Talk with your healthcare provider about what birth control method is right for you during this time.
  • are breastfeeding or plan to breastfeed. It is not known if BRIUMVI passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take BRIUMVI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of BRIUMVI?

The most common side effects of BRIUMVI include:

Infusion reactions, upper and lower respiratory tract infections, herpes infections, extremity pain, insomnia, and fatigue.

These are not all the possible side effects of BRIUMVI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to TG Therapeutics at 1-877-TGTXINC (1-877-848-9462).

For more important information, go to www.briumvi.com or call 1-833-BRIUMVI (1-833-274-8684).

Indication

BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

STAY IN THE KNOW

Sign up to receive the latest updates and resources for BRIUMVI

Join us for a Multiple Sclerosis (MS) educational event near you

Important Safety Information
Who should not receive BRIUMVI?
  • Do not receive BRIUMVI if you have an active hepatitis B virus (HBV) infection.
  • Do not receive BRIUMVI if you have had a life-threatening allergic reaction to BRIUMVI.
Indication
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Click or scroll to see IMPORTANT SAFETY INFORMATION AND INDICATION